Application 091305
- Type
- ANDA
- Sponsor
- INVAGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NAPROXEN | NAPROXEN | TABLET;ORAL | 250MG | No | No |
| 002 | NAPROXEN | NAPROXEN | TABLET;ORAL | 375MG | No | No |
| 003 | NAPROXEN | NAPROXEN | TABLET;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091305-001 | NAPROXEN | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | ||
| A091305-002 | NAPROXEN | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | ||
| A091305-003 | NAPROXEN | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091305-002 | NAPROXEN | 375MG | TABLET / ORAL | 2011-08-24 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091305-003 | NAPROXEN | 500MG | TABLET / ORAL | 2011-08-24 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091305-001 | NAPROXEN | 250MG | TABLET / ORAL | 2011-08-24 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A091305-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A091305-003 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A091305-001 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A091305-002 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A091305-003 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A091305-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A091305-002 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A091305-003 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A091305-001 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A091305-002 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A091305-003 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A091305-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A091305-002 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A091305-003 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A091305-001 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A091305-002 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A091305-003 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A091305-001 | AB | 1 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A091305-002 | AB | 1 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A091305-003 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A091305-001 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A091305-002 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A091305-003 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A091305-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A091305-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A091305-003 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A091305-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A091305-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A091305-003 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A091305-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A091305-002 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A091305-003 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A091305-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A091305-002 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A091305-003 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A091305-001 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A091305-002 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A091305-003 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| naproxen | NAPROXEN | Cipla USA Inc. | a9549a47-3fa4-4a2b-95ac-b00e43aedae7 | 2023-01-18 | Boxed warning, Warnings, Adverse reactions | 091305 ANDA091305 69097-855 69097-854 69097-853 |
| Naproxen | NAPROXEN | Exelan Pharmaceuticals, Inc. | 46dbdb95-a0d0-4410-8d64-b22763b12af7 | 2020-08-17 | Boxed warning, Warnings, Adverse reactions | 091305 ANDA091305 76282-341 76282-340 76282-342 |
| Naproxen | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | e2347581-90da-429a-b17c-cffd0039fb86 | 2017-10-23 | Boxed warning, Warnings, Adverse reactions | 091305 ANDA091305 43353-216 43353-211 43353-218 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 10544-939 | Naproxen | Naproxen | Blenheim Pharmacal, Inc. | ANDA | Current |
| 31722-340 | Naproxen | Naproxen | Camber Pharmaceuticals | ANDA | Current |
| 31722-341 | Naproxen | Naproxen | Camber Pharmaceuticals | ANDA | Current |
| 31722-342 | Naproxen | Naproxen | Camber Pharmaceuticals | ANDA | Current |
| 43353-201 | Naproxen | Naproxen | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-211 | Naproxen | Naproxen | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-216 | Naproxen | Naproxen | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-218 | Naproxen | Naproxen | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 50090-4396 | naproxen | naproxen | A-S Medication Solutions | ANDA | Current |
| 53002-3100 | naproxen | naproxen | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53002-3100 | naproxen | naproxen | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53002-3100 | naproxen | naproxen | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53002-3112 | naproxen | naproxen | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53002-3112 | naproxen | naproxen | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53002-3112 | naproxen | naproxen | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53002-3240 | naproxen | naproxen | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53002-3240 | naproxen | naproxen | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53002-3240 | naproxen | naproxen | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 53808-1053 | Naproxen | Naproxen | State of Florida DOH Central Pharmacy | ANDA | Current |
| 55700-463 | naproxen | naproxen | Lake Erie Medical DBA Quality Care Products LLC | ANDA | Current |
| 60687-268 | Naproxen | Naproxen | American Health Packaging | ANDA | Current |
| 60687-268 | Naproxen | Naproxen | American Health Packaging | ANDA | Current |
| 60760-460 | Naproxen | Naproxen | St. Mary's Medical Park Pharmacy | ANDA | Current |
| 61919-586 | NAPROXEN | NAPROXEN | DirectRX | ANDA | Current |
| 61919-586 | NAPROXEN | NAPROXEN | DirectRX | ANDA | Current |
| 67296-1374 | naproxen | naproxen | RedPharm Drug, Inc. | ANDA | Current |
| 68071-3029 | naproxen | naproxen | NuCare Pharmaceuticals, Inc. | ANDA | Current |
| 68071-3066 | naproxen | naproxen | NuCare Pharmaceuticals, Inc. | ANDA | Current |
| 68788-7456 | naproxen | naproxen | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-9878 | Naproxen | Naproxen | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 69097-853 | naproxen | naproxen | Cipla USA Inc. | ANDA | Current |
| 69097-853 | naproxen | naproxen | Cipla USA Inc. | ANDA | Current |
| 69097-854 | naproxen | naproxen | Cipla USA Inc. | ANDA | Current |
| 69097-854 | naproxen | naproxen | Cipla USA Inc. | ANDA | Current |
| 69097-855 | naproxen | naproxen | Cipla USA Inc. | ANDA | Current |
| 69097-855 | naproxen | naproxen | Cipla USA Inc. | ANDA | Current |
| 70518-0596 | naproxen | naproxen | REMEDYREPACK INC. | ANDA | Current |
| 70518-0596 | naproxen | naproxen | REMEDYREPACK INC. | ANDA | Current |
| 70518-1511 | naproxen | naproxen | REMEDYREPACK INC. | ANDA | Current |
| 70518-1511 | naproxen | naproxen | REMEDYREPACK INC. | ANDA | Current |
| 71335-0386 | naproxen | naproxen | Bryant Ranch Prepack | ANDA | Current |
| 71335-0386 | naproxen | naproxen | Bryant Ranch Prepack | ANDA | Current |
| 76282-340 | Naproxen | Naproxen | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-340 | Naproxen | Naproxen | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-340 | Naproxen | Naproxen | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-341 | Naproxen | Naproxen | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-341 | Naproxen | Naproxen | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-341 | Naproxen | Naproxen | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-342 | Naproxen | Naproxen | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-342 | Naproxen | Naproxen | Exelan Pharmaceuticals, Inc. | ANDA | Current |
| 76282-342 | Naproxen | Naproxen | Exelan Pharmaceuticals, Inc. | ANDA | Current |